drugset / Trial / NCT02338856

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

NCT02338856 ↗

Phase 1 Completed 11 enrolled Yungjin Pharm. Co., Ltd.
RandomizedParallel-groupQuadruple-blindScreening

Summary

The purpose of this study is to investigate the safety and tolerability of MB12066 after multiple dose and to investigate the pharmacokinetic characteristics of MB12066 after multiple dose.

Timeline

Start
2015-01
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject LAPACHONE Small molecule 100 mg —

Indications